incensole acetate

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameincensole acetate
Drug Alias NameTRPV3 agonist (Hebrew University of Jerusalem/BioLineRx)EDP-18 program
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 3 stimulants
TargetsTransient receptor potential cation channel subfamily V member 3
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Hebrew University Of Jerusalem
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx LtdThe Hebrew University Of Jerusalem
Active IndicationsN/A
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A